
Study finds heart disease drug promotes bone growth
New research has shown that phosphodiesterase (PDE) 3 inhibitors, used for treating thrombosis, heart diseases, and asthma, can promote bone growth by stimulating C-type natriuretic peptide (CNP) signalling. Scientists have found that PDE3 inhibitors stimulate key signalling pathways that trigger Ca2+ influx into bone cells, promoting extracellular… Read More
